The problem of azole resistance in Candida

Journal de Mycologie Medicale

Volumn 6, Issue 2 SUPPL., 1996, Pages 12-19

  Dupont, B F ^a   Dromer, F ^b   Improvisi, L ^b  

^a INSTITUT PASTEUR   (France)

^b NONE

Author keywords

Azole resistance; Candida; Fluconazole; HIV infection; Itraconazole; Oropharyngeal candidiasis

Indexed keywords

AMPHOTERICIN B; CLOTRIMAZOLE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NYSTATIN; PYRROLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANDIDA ALBICANS; CANDIDIASIS; CONFERENCE PAPER; DRUG EFFICACY; ESOPHAGITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORBIDITY; MOUTH INFECTION; ORAL DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION;

EID: 0030480222     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Baily GG, Perry FM, Denning DW, Mandai BK. Fluconazole-resistant candidosis in an HIV cohort. AIDS 1994;8:787-92.
2. Barchiesi F, Hollis RJ, McCough DA, Scalise G, Rinaldi MG, Pfaller MA. DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS. Clin Infect Dis 1995;20:634-40.
3. Bart-Delabesse E, Boiron P, Carlotti A, Dupont B. Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole. J Clin Microbiol 1993;37:2933-7.
4. Chavanet P, Lopez J, Grappin M, et al. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients. AIDS 1994;8:945-50.
5. Dellion S, Improvisi L, Dupont B, Dromer F. Diversity among yeasts isolated from patients with AIDS and oral candidosis: focus on fluconazole susceptibility testing results. J Mycol Med 1995;5:98-101.
6. Dromer F, Improvisi L, Bart-Delabesse E, Dupont B. Transmission of Candida albicans (CA) isolates between partners in HIV-infected couples. In: Abstracts of the 35th ICAAC; 1995; San Francisco, Calif. Abstract LM 89.
7. Drouhet E, Dupont B, Improvisi L, Viviani MA, Tortorano AM. In: Iwata K, Vanden Bossche H, eds. Disc agar diffusion and microplate automatized technics for in vitro evaluation of antifungal agents on yeasts and sporulated pathogenic fungi. In Vitro and In Vivo Evaluation of Antifungal Agents. New York, NY: Elsevier Science Publishers; 1986.
8. Dupont B. Azole antifungal agents: emerging and inherent resistance. Curr Opin Infect Dis 1995;8:424-7.
9. Dupont B, Improvisi L, Eliaszewicz E, Pialoux G, and the GEMO. Resistance of Candida albicans to fluconazole in AIDS patients. In: Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy of the American Society for Microbiology; 1992; Washington, DC. Abstract 1203.
10. Espinel-Ingroff A, Kerkering TM, Goldson PR, Shadomy S. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol 1991;29:1089-94.
11. Garcia-Hermoso D, Dromer F, Improvisi L, Provost F, Dupont B. Fluconazole concentrations in saliva from AIDS patients with oropharyngeal candidosis refractory to treatment with fluconazole. Antimicrob Agents Chemother 1995;39:656-60.
12. Graybill JR, Najvar LK, Holmberg JD, Correa A, Luther MF. Fluconazole treatment of Candida albicans infection in mice: does in vitro susceptibility predict in vivo response? Antimicrob Agents Chemother 1995;39:2197-200.
13. Heinic GS, Stevens DA, Greenspan D, et al. Fluconazole-resistant Candida in AIDS patients. Oral Surg Oral Med Oral Pathol 1993;76:711-15.
14. Hitchcock CA, Pye GW, Troke PF, Johnson EM, Warnock DW. Fluconazole resistance in Candida glabrata. Antimicrob Agents Chemother 1993;37:1962-5.
15. Holt RJ, Azmi A. Miconazole-resistant Candida. Lancet 1978;i: 50-1.
16. Horsburgh CR, Kirkpatrick CH. Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients. Am J Med 1983;74(1B):23-9.
17. Johnson EM, Warnock DW, Luker J, Porter SR, Scully C. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. J Antimicrob Chemother 1995;35:103-14.
18. Le Guennec R, Reynes J, Mallie M, Pujol C, Janbon F, Bastide JM. Fluconazole and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities. J Clin Microbiol 1995;33: 2732-7.
19. Maenza JR, Keruly JC, Moore RD, Chaison RE, Merz WG, Gallant JE. Risk factors for fluconazole resistant candidiasis in human immunodeficiency virus-infected patients. J Infect Dis 1996; 173:219-25.
20. McCullough M, Hume S. A longitudinal study of the change in resistance patterns and genetic relationship of oral Candida albicans from HIV-infected patients. J Med Vet Mycol 1995;33:33-7.
21. Millon L, Manteaux A, Reboux G, et al. Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. J Clin Microbiol 1994;32:1115-18.
22. Odds FC. Review: resistance of yeasts to azole-derivatives antifungals. J Antimicrob Chemother 1993;57:463-71.
23. Odds FC, Dams G, Just G, Lewi P. Susceptibilities of Candida spp. to antifungal agents visualized by two dimensional scatterplots of relative growth. Antimicrob Agents Chemother 1996;40:588-94.
24. Parkinson T, Falconer DJ, Hitchcock CA. Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata. Antimicrob Agents Chemother 1995;39:1696-9.
25. Pfaller MA, Rhine-Chalberg J, Redding SW, et al. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol 1994;32:59-64.
26. Powderly WG, Finkelstein DM, Feinberg J, et al. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N Engl J Med 1995;16:700.
27. Redding S, Smith J, Farinacci G, et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis 1994;18:240-2.
28. Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995;39:1-8.
29. Reynes J, Malli M, Andr D, Janbon F, Bastide JM. Traitement et prophylaxie secondaire par fluconazole des candidoses oropharynges des sujets VIH+. Analyse mycologique des checs. Pathol Biol 1992;40:513-17.
30. Ruhnke M, Eigler A, Engelmann E, Geiseler B, Trautmann M. Correlation between antifungal susceptibility testing of Candida isolates from patients with HIV infection and clinical results after treatment with fluconazole. Infection 1994;22:132-6.
31. Ryley JF, Wilson RG, Barret-Bee KJ. Azole resistance in Candida albicans. Sabouraudia 1984;22:53-63.
32. Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 1995;39:2378-86.
33. Smith KJ, Warnock DW, Kennedy CTC, et al. Azole resistance in Candida albicans. J Med Vet Mycol 1986;24:133-44.
34. Troillet N, Durussel C, Bille J, Glauser MP, Chave JP. Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients. Eur J Clin Microbiol Infect Dis 1993;12:911-15.
35. Vanden Bossche H, Marichal P, Odds FC. Molecular mechanisms of drug resistance in fungi. Trends Microbiol 1994;2:393-400.
36. Vanden Bossche H, Warnock DW, Dupont B, et al. Mechanisms and clinical impact of antifungal drug resistance. J Med Vet Mycol 1994;32:189-202.
37. Vuffray A, Durussel C, Boerlin P, et al. Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients. AIDS 1994;8:708-9.
38. Warnock DW, Johnson EM, Richardson MD, Vickers CFH. Modified response to ketoconazole of Candida albicans from a treatment failure. Lancet 1983;i:642-3.
39. Wheat J, Vanden Bossche H, Marical P. Mechanisms for resistance of Histoplasma capsulatum. In: Abstracts of the 3rd Conference of Retroviruses and Opportunistic Infections; 1996; Washington, DC. Abstract 565.
40. White A, Goetz MB. Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review. Clin Infect Dis 1994;19:687-92.
41. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991;325:1274-7.